vs

Side-by-side financial comparison of DaVita (DVA) and Synopsys (SNPS). Click either name above to swap in a different company.

DaVita is the larger business by last-quarter revenue ($3.6B vs $2.3B, roughly 1.6× Synopsys). Synopsys runs the higher net margin — 19.9% vs 6.5%, a 13.4% gap on every dollar of revenue. On growth, Synopsys posted the faster year-over-year revenue change (50.6% vs 12.3%). Over the past eight quarters, Synopsys's revenue compounded faster (16.9% CAGR vs 6.6%).

DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.

Synopsys, Inc. is an American multinational electronic design automation (EDA) company headquartered in Sunnyvale, California, that focuses on design and verification of silicon chips, electronic system-level design and verification, and reusable components. Synopsys supplies tools and services to the semiconductor design and manufacturing industry.

DVA vs SNPS — Head-to-Head

Bigger by revenue
DVA
DVA
1.6× larger
DVA
$3.6B
$2.3B
SNPS
Growing faster (revenue YoY)
SNPS
SNPS
+38.3% gap
SNPS
50.6%
12.3%
DVA
Higher net margin
SNPS
SNPS
13.4% more per $
SNPS
19.9%
6.5%
DVA
Faster 2-yr revenue CAGR
SNPS
SNPS
Annualised
SNPS
16.9%
6.6%
DVA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DVA
DVA
SNPS
SNPS
Revenue
$3.6B
$2.3B
Net Profit
$234.2M
$448.7M
Gross Margin
71.0%
Operating Margin
15.5%
5.4%
Net Margin
6.5%
19.9%
Revenue YoY
12.3%
50.6%
Net Profit YoY
43.8%
-59.7%
EPS (diluted)
$3.22
$2.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DVA
DVA
SNPS
SNPS
Q1 26
$3.6B
Q4 25
$3.6B
$2.3B
Q3 25
$3.4B
$1.7B
Q2 25
$3.4B
$1.6B
Q1 25
$3.2B
$1.5B
Q4 24
$3.3B
$1.5B
Q3 24
$3.3B
$1.5B
Q2 24
$3.2B
$1.5B
Net Profit
DVA
DVA
SNPS
SNPS
Q1 26
$234.2M
Q4 25
$234.2M
$448.7M
Q3 25
$150.3M
$242.5M
Q2 25
$199.3M
$345.3M
Q1 25
$162.9M
$295.7M
Q4 24
$259.3M
$1.1B
Q3 24
$214.7M
$408.1M
Q2 24
$222.7M
$292.1M
Gross Margin
DVA
DVA
SNPS
SNPS
Q1 26
Q4 25
71.0%
Q3 25
78.1%
Q2 25
80.2%
Q1 25
81.4%
Q4 24
78.3%
Q3 24
80.9%
Q2 24
79.4%
Operating Margin
DVA
DVA
SNPS
SNPS
Q1 26
15.5%
Q4 25
15.5%
5.4%
Q3 25
14.8%
9.5%
Q2 25
15.9%
23.5%
Q1 25
13.6%
17.3%
Q4 24
17.2%
20.3%
Q3 24
16.4%
23.6%
Q2 24
15.9%
22.8%
Net Margin
DVA
DVA
SNPS
SNPS
Q1 26
6.5%
Q4 25
6.5%
19.9%
Q3 25
4.4%
13.9%
Q2 25
5.9%
21.5%
Q1 25
5.1%
20.3%
Q4 24
7.9%
74.4%
Q3 24
6.6%
26.7%
Q2 24
7.0%
20.1%
EPS (diluted)
DVA
DVA
SNPS
SNPS
Q1 26
$3.22
Q4 25
$3.22
$2.44
Q3 25
$2.04
$1.50
Q2 25
$2.58
$2.21
Q1 25
$2.00
$1.89
Q4 24
$3.08
$7.13
Q3 24
$2.50
$2.61
Q2 24
$2.50
$1.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DVA
DVA
SNPS
SNPS
Cash + ST InvestmentsLiquidity on hand
$700.7M
$3.0B
Total DebtLower is stronger
$10.2B
$13.5B
Stockholders' EquityBook value
$-651.1M
$28.3B
Total Assets
$17.5B
$48.2B
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DVA
DVA
SNPS
SNPS
Q1 26
$700.7M
Q4 25
$700.7M
$3.0B
Q3 25
$736.5M
$2.6B
Q2 25
$739.4M
$14.3B
Q1 25
$511.9M
$3.8B
Q4 24
$846.0M
$4.1B
Q3 24
$1.1B
$2.0B
Q2 24
$437.2M
$1.7B
Total Debt
DVA
DVA
SNPS
SNPS
Q1 26
$10.2B
Q4 25
$10.2B
$13.5B
Q3 25
$10.2B
$14.3B
Q2 25
$10.1B
$10.1B
Q1 25
$9.6B
Q4 24
$9.2B
Q3 24
$9.3B
Q2 24
$8.5B
Stockholders' Equity
DVA
DVA
SNPS
SNPS
Q1 26
$-651.1M
Q4 25
$-651.1M
$28.3B
Q3 25
$-571.9M
$27.6B
Q2 25
$-369.6M
$9.9B
Q1 25
$-267.1M
$9.3B
Q4 24
$121.1M
$9.0B
Q3 24
$386.7M
$7.7B
Q2 24
$632.9M
$7.2B
Total Assets
DVA
DVA
SNPS
SNPS
Q1 26
$17.5B
Q4 25
$17.5B
$48.2B
Q3 25
$17.6B
$48.2B
Q2 25
$17.5B
$23.8B
Q1 25
$17.1B
$13.0B
Q4 24
$17.3B
$13.1B
Q3 24
$17.5B
$11.6B
Q2 24
$17.0B
$11.0B
Debt / Equity
DVA
DVA
SNPS
SNPS
Q1 26
Q4 25
0.48×
Q3 25
0.52×
Q2 25
1.01×
Q1 25
Q4 24
75.76×
Q3 24
23.95×
Q2 24
13.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DVA
DVA
SNPS
SNPS
Operating Cash FlowLast quarter
$639.7M
Free Cash FlowOCF − Capex
$605.2M
FCF MarginFCF / Revenue
26.8%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
1.43×
TTM Free Cash FlowTrailing 4 quarters
$1.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DVA
DVA
SNPS
SNPS
Q1 26
Q4 25
$540.7M
$639.7M
Q3 25
$841.5M
$671.0M
Q2 25
$324.2M
$275.4M
Q1 25
$180.0M
$-67.5M
Q4 24
$547.6M
$562.8M
Q3 24
$810.4M
$455.4M
Q2 24
$798.8M
$476.6M
Free Cash Flow
DVA
DVA
SNPS
SNPS
Q1 26
Q4 25
$395.3M
$605.2M
Q3 25
$675.4M
$632.4M
Q2 25
$203.1M
$219.8M
Q1 25
$36.8M
$-108.2M
Q4 24
$377.0M
$558.4M
Q3 24
$671.4M
$415.4M
Q2 24
$674.1M
$438.2M
FCF Margin
DVA
DVA
SNPS
SNPS
Q1 26
Q4 25
10.9%
26.8%
Q3 25
19.7%
36.3%
Q2 25
6.0%
13.7%
Q1 25
1.1%
-7.4%
Q4 24
11.4%
37.3%
Q3 24
20.6%
27.2%
Q2 24
21.2%
30.1%
Capex Intensity
DVA
DVA
SNPS
SNPS
Q1 26
Q4 25
4.0%
1.5%
Q3 25
4.9%
2.2%
Q2 25
3.6%
3.5%
Q1 25
4.4%
2.8%
Q4 24
5.2%
0.3%
Q3 24
4.3%
2.6%
Q2 24
3.9%
2.6%
Cash Conversion
DVA
DVA
SNPS
SNPS
Q1 26
Q4 25
2.31×
1.43×
Q3 25
5.60×
2.77×
Q2 25
1.63×
0.80×
Q1 25
1.10×
-0.23×
Q4 24
2.11×
0.51×
Q3 24
3.77×
1.12×
Q2 24
3.59×
1.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DVA
DVA

Segment breakdown not available.

SNPS
SNPS

License And Maintenance$940.7M42%
Other$640.0M28%
Design IP Segment$407.1M18%
KR$236.9M11%
Sales Based Royalties$30.1M1%

Related Comparisons